Betting Against Beta on Euronext Large Caps

Betting against beta on Euronext large caps across Paris Amsterdam Brussels Milan. 252-day betas versus EURO STOXX 50 terciles leverage cap 2.5 15 bps

Abstract

Betting against beta, Frazzini and Pedersen (2014), is the claim that leverage-constrained investors bid up high-beta names, so a book that is long low beta and short high beta, with the two legs scaled to a similar market exposure, earns a premium. A minimum-variance optimiser often lands near low-beta names as a side effect. This page forces the comparison: the sort key is beta, and the leverage is explicit.

The names are the Euronext large-cap panel: Paris (*.PA), Amsterdam (*.AS), Brussels (*.BR), and Milan (*.MI). Beta is measured against the EURO STOXX 50. The same download feeds the factor-momentum page and the variance-premium page.

Beta, leverage, and the book

Beta uses 252 daily simple returns ending the day before the rebalance:

The low third and the high third are the two legs. Let and be the average betas inside those legs, floored at 0.15 so a near-zero beta cannot demand infinite leverage. The leg multipliers are

Names inside a leg are equal-weighted and then multiplied by . The low-beta leg is positive. The high-beta leg is negative. One-way cost is 15 bps on L1 turnover, which matters because a 2.5 leverage cap makes the gross book larger than a unit long-short.

The reported mean is the Newey–West test on this net monthly return. The EURO STOXX 50 wealth path is the scale reference. The book is not constrained to a beta of zero after the fact; the cap at 2.5 leaves a residual market exposure whenever the raw betas are far from one.

Empirical results

Cards include the latest low-beta and high-beta sleeve averages so the leverage applied at the last rebalance is visible. The wealth chart compounds the net book against the EURO STOXX 50. Because the book is levered and short, a drawdown can exceed the index drawdown even when the average beta gap is small.

Sample
2012-02-29 → 2026-11-30
Sleeve
Euronext large-cap constituents
Benchmark
^STOXX50E
Series kept
82

Frazzini–Pedersen style book on 82 Euronext names. Beta is the prior 252 sessions versus ^STOXX50E. Long the low-beta third, short the high-beta third, each sleeve levered toward beta 1 with a cap of 2.5, 15 bps one-way. Net Sharpe 0.79.

BAB ann. return
14.9%
BAB ann. vol
20.0%
BAB Sharpe
0.79
BAB max drawdown
-26.7%
Last low-beta sleeve β
0.15
Last high-beta sleeve β
1.32

Growth of 1. Dates are thinned when the path is daily.

TestEstimatetpReading
Mean monthly BAB return1.3%3.280.001Newey–West test. Leverage is 1/β inside each tercile, capped at 2.5, so the legs are closer to unit market beta before the long-short.

Calendar-year returns

YearStrategyBenchmark
201225.6%8.7%
201320.1%18.0%
201429.8%1.1%
201532.8%4.8%
2016-8.1%0.1%
201717.6%6.5%
201813.6%-14.8%
20198.8%25.5%
20202.6%-4.7%
202126.6%20.6%
2022-10.4%-11.9%
2023-0.9%19.2%
20246.8%7.7%
202522.8%19.0%
202650.1%10.4%

Series that entered the sample

TickerNameFirstLastDays
MC.PALVMH2012-01-022026-11-113802
OR.PAL'Oréal2012-01-022026-11-113802
TTE.PATotalEnergies2012-01-022026-11-113802
SAN.PASanofi2012-01-022026-11-113802
AIR.PAAirbus2012-01-022026-11-113802
SU.PASchneider Electric2012-01-022026-11-113802
AI.PAAir Liquide2012-01-022026-11-113802
BNP.PABNP Paribas2012-01-022026-11-113802
DG.PAVinci2012-01-022026-11-113802
RMS.PAHermès2012-01-022026-11-113802
EL.PAEssilorLuxottica2012-01-022026-11-113802
CS.PAAXA2012-01-022026-11-113802
SAF.PASafran2012-01-022026-11-113802
BN.PADanone2012-01-022026-11-113802
RI.PAPernod Ricard2012-01-022026-11-113802
CAP.PACapgemini2012-01-022026-11-113802
ACA.PACrédit Agricole2012-01-022026-11-113802
GLE.PASociété Générale2012-01-022026-11-113802
CA.PACarrefour2012-01-022026-11-113802
DSY.PADassault Systèmes2012-01-022026-11-113802
ENGI.PAEngie2012-01-022026-11-113802
HO.PAThales2012-01-022026-11-113802
KER.PAKering2012-01-022026-11-113802
LR.PALegrand2012-01-022026-11-113802
ML.PAMichelin2012-01-022026-11-113802
ORA.PAOrange2012-01-022026-11-113802
PUB.PAPublicis2012-01-022026-11-113802
RNO.PARenault2012-01-022026-11-113802
SGO.PASaint-Gobain2012-01-022026-11-113802
STLAP.PAStellantis2012-01-022026-11-113802
URW.PAUnibail-Rodamco-Westfield2023-04-142026-11-11915
VIE.PAVeolia2012-01-022026-11-113802
ALO.PAAlstom2012-01-022026-11-113802
MT.PAArcelorMittal2012-01-032018-05-071596
EDEN.PAEdenred2012-01-022026-11-113802
ERF.PAEurofins2012-01-022026-11-113802
ASML.ASASML2012-01-022026-11-113802
SHELL.ASShell2012-01-022026-11-113802
INGA.ASING2012-01-022026-11-113802
ADYEN.ASAdyen2018-06-132026-11-112156
PRX.ASProsus2019-09-112026-11-111837
PHIA.ASPhilips2012-01-022026-11-113802
HEIA.ASHeineken2012-01-022026-11-113802
WKL.ASWolters Kluwer2012-01-022026-11-113802
AD.ASAhold Delhaize2012-01-022026-11-113802
ASM.ASASM International2012-01-022026-11-113802
BESI.ASBE Semiconductor2012-01-022026-11-113802
AKZA.ASAkzo Nobel2012-01-022026-11-113802
DSFIR.ASDSM-Firmenich2023-04-182026-11-11913
NN.ASNN Group2014-07-022026-11-113165
UMG.ASUniversal Music2021-09-212026-11-111318
KPN.ASKPN2012-01-022026-11-113802
IMCD.ASIMCD2014-06-272026-11-113168
ABI.BRAB InBev2012-01-022026-11-113800
KBC.BRKBC2012-01-022026-11-113800
UCB.BRUCB2012-01-022026-11-113800
ACKB.BRAckermans & van Haaren2012-01-022026-11-113800
AGS.BRAgeas2012-01-022026-11-113800
SOLB.BRSolvay2012-01-022026-11-113800
UMI.BRUmicore2012-01-022026-11-113800
GBLB.BRGroupe Bruxelles Lambert2012-01-022026-11-113800
DIE.BRD'Ieteren2012-01-022026-11-113800
ELI.BRElia2012-01-022026-11-113800
ENI.MIEni2012-01-022026-11-113773
ENEL.MIEnel2012-01-022026-11-113773
ISP.MIIntesa Sanpaolo2012-01-022026-11-113773
UCG.MIUniCredit2012-01-022026-11-113773
RACE.MIFerrari2016-01-042026-11-112761
STMMI.MISTMicroelectronics2012-01-022026-11-113773
G.MIGenerali2012-01-022026-11-113773
LDO.MILeonardo2012-01-022026-11-113773
CPR.MICampari2012-01-022026-11-113773
MONC.MIMoncler2013-12-162026-11-113276
PRY.MIPrysmian2012-01-022026-11-113773
SRG.MISnam2012-01-022026-11-113773
TRN.MITerna2012-01-022026-11-113773
MB.MIMediobanca2012-01-022026-11-113773
BAMI.MIBanco BPM2012-01-022026-11-113773
REC.MIRecordati2012-01-022026-11-113773
NEXI.MINexi2019-04-182026-11-111923
A2A.MIA2A2012-01-022026-11-113773
PIRC.MIPirelli2017-10-042026-11-112312

Sharpe ratios use a zero risk-free rate. Costs, where charged, are a flat one-way bps haircut on weight turnover. Source: Yahoo Finance. Assignment seed 20261113.

What this does not show

Frazzini–Pedersen betas are shrunk toward one and estimated with overlapping logs on a correlation-weighted window. The beta here is an ordinary 252-day OLS beta. The rank order is similar. The leverage is not identical.

A short leg in Milan or Brussels names is not the same operational object as a short leg in S&P 500 names. Borrow, tax, and the euro funding rate are outside the 15 bp haircut.

Yahoo Finance adjusted closes are not a point-in-time index membership file. The constituent lists are a liquid large-cap panel, fixed in the repository, not the official index as it stood on each rebalance date.

The risk-free rate is set to zero in every Sharpe ratio. A local bill rate would lower the ratios and would not, by itself, change a long-short spread.

Costs are a flat one-way haircut on weight turnover. They do not include borrow fees, lot-size rules, auction imbalance, stamp duty, or the Shanghai and Hong Kong short-sale bans that bind a live short book.

This is a research record. It is not a recommendation to trade the sleeve.

QuantifiedTrader logoQuantifiedTrader

Independent quantitative research on trading methods, backtesting, and market analytics.

Research disclaimer

QuantifiedTrader is operated by an independent quantitative research group. We study, document, and compare different methods of trading, portfolio construction, risk management, and investment analysis. Our work is exploratory and academic in nature—we build tools, run backtests, and publish findings to advance understanding, not to promote any particular strategy or product.

Not investment advice. Nothing on this website constitutes investment, trading, financial, tax, legal, or other professional advice. We do not recommend, endorse, or solicit the purchase or sale of any security, derivative, or financial instrument, nor do we suggest that any strategy, model, or result presented here is suitable for any individual or institution. Any examples, simulations, or performance figures are illustrative research outputs only.

No client or advisory relationship. We do not provide investment advisory, brokerage, portfolio-management, custody, or asset-management services to any person or entity. Browsing this site, using our tools, or contacting us does not create a client, fiduciary, or advisory relationship. We do not manage money on behalf of third parties and do not act as agents for any financial institution.

Research & education only. Content, datasets, backtests, charts, code, and software made available here are for informational and educational research. Materials may be incomplete, simulated, hypothetical, or derived from third-party sources that we do not control. Past performance, backtested results, and historical analyses are not indicative of future results. Market conditions change; models may fail; assumptions may be wrong. You are solely responsible for evaluating any information and for all decisions you make.

No responsibility or liability. To the fullest extent permitted by applicable law, QuantifiedTrader and its contributors disclaim all responsibility and liability for any loss, damage, cost, or expense—direct or indirect—arising from access to, use of, or reliance on this website, its content, or its tools. All materials are provided “as is” and “as available,” without warranties of any kind, whether express or implied, including but not limited to accuracy, completeness, fitness for a particular purpose, or non-infringement.

Non-commercial research sharing. This site does not aim to profit from the knowledge, tools, or datasets published here. Materials are shared for non-commercial research and learning, subject to applicable open-source or site terms where noted. We are a research collective, not a commercial product or service provider.

Contact. For questions about this notice, the site, or published research materials, contact support@quantedx.com. Correspondence is for administrative and research purposes only and does not constitute advice or create any professional obligation on our part.

© 2026 QuantifiedTrader. All rights reserved.